BioTech IP Review

Chen et al. (2021)

Published in: Cell 184(22):5635–5652 (Oct 28, 2021)
DOI: 10.1016/j.cell.2021.09.018
Lead Author: Peter J. Chen and colleagues (including David R. Liu)

---

What This Study Covers

This paper made a major advance in CRISPR prime editing — a precise genome editing technology that can introduce specific substitutions, insertions, and deletions into DNA without making double‑strand breaks. While prime editing had already shown promise, its efficiency and accuracy in many cell types were limited.

Key contributions include:

• Identifying cellular factors that limit editing: Using genome‑wide CRISPRi screens, the researchers showed that the DNA mismatch repair (MMR) pathway interferes with accurate prime editing and increases unwanted mutations.
• Developing improved systems (PE4/PE5): They engineered prime editing systems (PE4 and PE5) that co‑express an MMR‑inhibiting protein, boosting editing efficiency by ~7.7‑fold (PE4) and ~2.0‑fold (PE5) compared with earlier systems.
• Optimizing the prime editor protein (PEmax): They also created a more efficient prime editor (PEmax) with enhanced activity across many mammalian cell types, improving outcomes and reducing unwanted additions/deletions.
• Demonstrating broad improvement: Across 191 different edits in seven mammalian cell types, the enhanced systems significantly improved editing precision and efficiency.

---

Why It’s Important

1. Advances Genome Editing Precision

Prime editing is seen as a next‑generation genome editing tool because it can make defined DNA changes without cutting both strands of DNA (which reduces unintended breaks and errors). These improvements make the technology more reliable for research and therapeutic use.

2. Enables Better Therapeutic Development

Higher efficiency and accuracy are critical if prime editing is to be used for correcting disease‑causing mutations, modeling disease, or engineering cells for therapy. By overcoming cellular barriers like mismatch repair, this work brings prime editing closer to real‑world clinical applications.

3. Broad Applicability Across Cell Types

The enhancements work across multiple mammalian cell types, making the method more generally applicable for both basic research and biotechnology applications such as cell engineering.

---

Summary

This paper showed how to make the prime editing version of CRISPR much better by understanding and manipulating how cells respond to DNA changes. The researchers made new editing systems that work more efficiently and accurately by dampening cellular repair pathways that interfere with intended edits — a major step toward using precise genome editing for research and therapeutic purposes.